131 – 140 of 306
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?
(
- Contribution to journal › Scientific review
-
Mark
Validation of an improved scale for rating L-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists
(
- Contribution to journal › Article
-
Mark
Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model
(
- Contribution to journal › Article
-
Mark
Pathogenic effects of alpha-synuclein: modifications and toxicity
2016)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Continuous dopaminergic stimulation therapy for Parkinson's disease - Recent advances
(
- Contribution to journal › Article
-
Mark
Impulse Control Disorders : The Continuum Hypothesis
(
- Contribution to journal › Article
-
Mark
A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists
(
- Contribution to journal › Article
-
Mark
The association between indicators of health and housing in people with Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Brain repair and reprogramming : the route to clinical translation
(
- Contribution to journal › Scientific review
-
Mark
Fall-related activity avoidance in relation to a history of falls or near falls, fear of falling and disease severity in people with Parkinson's disease
(
- Contribution to journal › Article